Kimberly LovettRockwell M.D.

Dr. Kimberly Lovett Rockwell's experience as a board certified physician informs her approach to providing health care legal and regulatory counsel to health care and non-health care entities related to compliance, litigation, internal investigation, and government investigation matters.

Kimberly advises clients on a range of state and federal legal and regulatory issues, including health care fraud, waste, and abuse laws and investigations arising under the False Claims Act (FCA), the Anti-Kickback Statute (AKS), civil monetary penalties, and fee-splitting laws; U.S. Food and Drug Administration (FDA) regulations; medical necessity determinations based upon clinical practice guidelines and evidence-based medicine; compliance program organization and implementation; telehealth and digital health practice structuring, restrictions, and reimbursement; supervision of non-physician providers; and corporate practice of medicine prohibitions. Throughout the COVID-19 public health crisis, she also advised large health care and non-health care corporate clients on policies and procedures for temperature screening, face covering, COVID-19 testing, and return-to-work protocols. She also advised health care clients looking to expand telehealth programming in response to the pandemic.

Kimberly has held academic medicine appointments at Stanford University and the University of California, San Diego and has given lectures on health policy issues, including telehealth, health care, and Medicare reform, and quality measurement. She has published book chapters and articles in peer-reviewed journals, including the Journal of the American Medical Association and Nature Reviews Cancer. Kimberly has served on the board of directors for the Michigan State Medical Society and the San Diego County Medical Society and on committees for the California Medical Association. She is a long-standing member of the American Medical Association and continues to serve primary care patients.